Minodronic acid
CAS No. 180064-38-4
Minodronic acid( —— )
Catalog No. M37531 CAS No. 180064-38-4
Minodronic acid(YM-529) is a P2X2/3 receptor antagonist with anticancer activity, directly or indirectly inhibiting the proliferation of cancer cells and inducing apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 38 | Get Quote |
|
| 25MG | 59 | Get Quote |
|
| 50MG | 86 | Get Quote |
|
| 100MG | 116 | Get Quote |
|
| 500MG | 293 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMinodronic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionMinodronic acid(YM-529) is a P2X2/3 receptor antagonist with anticancer activity, directly or indirectly inhibiting the proliferation of cancer cells and inducing apoptosis.
-
DescriptionMinodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetP2X Receptor
-
RecptorP2X Receptor | Apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number180064-38-4
-
Formula Weight322.15
-
Molecular FormulaC9H12N2O7P2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 5 mg/mL (15.52 mM) DMSO : < 1 mg/mL (insoluble or slightly soluble)
-
SMILESOC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sato K, et al. A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo. Br J Cancer. 2006 Nov 20;95(10):1354-61.?
molnova catalog
related products
-
GSK-1482160
GSK-1482160 is a CNS-penetrant negative allosteric modulator of P2X7 receptor with oral activity.
-
Lu AF27139
Lu AF27139 is an effective and selective antagonist of P2X7 receptor (IC50s of 12 and 2.4 nM for human and rat, Kis of 22, 54, and 13 nM for mouse, human, and rat, respectively). Lu AF27139 can be used in CNS diseases studies.
-
JNJ-54175446
JNJ-54175446 (JNJ-5446) is a CNS-permeable and selective P2X7 receptor antagonist that attenuates the release of IL-1β/IL-18 from microglia, and may be used in the study of depression.
Cart
sales@molnova.com